MSDC-0602K has shown substantial decreases in glucose, insulin, liver enzymes, and the non-alcoholic fatty liver disease activity score (NAS) in patients with biopsy-confirmed MASH and fibrosis (F1-F3) with minimal side effects, 21 prompting a phase 3 study to assess the benefits of MSDC-0602K on glycemic control and cardiovascular outcomes in patients with pre-T2D or T2D and MASLD/MASH (NCT03970031)
PubMed laboratory research record [PMID: 17676307] PubMed record related to this compound for laboratory literature review
Vessel's fast-acting oral dissolving strip delivers CJC-1295 + Ipamorelin in a convenient, needle-free formatbuilt for modern recovery and performance
Text us to ask questions or schedule a visitwere here to help, whether you prefer in-person care in Spring, Kingwood, The Woodlands, or a virtual consult
Patients with excess abdominal skin causing rashes, irritation, hygiene difficulties, infections, or functional limitations may be candidates for panniculectomy surgery after provider evaluation